Eucalyptus
Eucalyptus is a Sydney-based telehealth operator that runs multiple demographic-focused online clinics (Juniper, Pilot, Kin, Software, Compound) on a shared proprietary platform, delivering subscription-based chronic care across Australia, the UK, Germany, Japan and Canada.
- Company typePrivate
- Founded2019
- HeadquartersSydney, Australia
- Headcount251–500
- GTM typeB2C
- OfferingServices
What Eucalyptus does
Eucalyptus is a Sydney-headquartered digital telehealth operator founded in 2019 that runs a portfolio of demographic-focused online clinics on a shared proprietary platform. Its sub-brands include Juniper (women's weight management, launched 2021, operating in Australia, UK, Germany and Japan), Pilot (men's health, founded 2019), Kin (reproductive healthcare, founded 2020), Software (clinical-grade tele-skincare, founded 2020), and Compound. The underlying Eucalyptus platform is custom-built and includes modules for consultation, pathology, flexible plans, purchasing, chat, tracking and medical records, with role-specific views for practitioners and patients; it integrates with Australia's eRx electronic prescription exchange and IHI database, and meets NHS DSPT requirements and CQC/GPhC regulations in the UK. The company has facilitated over 1 million practitioner consultations and serves more than 775,000 customers, with an in-house multidisciplinary clinical team of 80+ practitioners across GPs, nurse practitioners, pharmacists and dietitians.
Eucalyptus generates revenue primarily through subscription-based care programs that bundle clinician consultations, ongoing coaching, prescriptions and shipped treatments across its four consumer clinics. The flagship Juniper program combines pharmacotherapy (semaglutide and tirzepatide) with multidisciplinary health coaching delivered via an award-winning native mobile app and a proprietary trends engine; Software additionally sells custom and over-the-counter skincare through Priceline Pharmacy retail in Australia. The company does not publicly disclose specific program pricing.
In February 2026, NYSE-listed Hims & Hers Health announced a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million in cash at closing plus deferred and earnout payments through early 2029; the deal closed in June 2026. At acquisition announcement, Eucalyptus disclosed ARR exceeding US$450 million with triple-digit year-over-year growth across every quarter of 2025. Co-founder Tim Doyle transitioned to SVP of International at Hims & Hers, and the post-acquisition entity has subsequently announced collaborations with Novo Nordisk for branded Wegovy/Ozempic distribution and an AI agent integration with Amigo.
Eucalyptus firmographics
Firmographics- Name
- Eucalyptus
- Legal name
- EUC Services Pty Ltd
- Website
- https://eucalyptus.health
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 251–500 employees
- Short description
- Eucalyptus is a Sydney-based telehealth operator that runs multiple demographic-focused online clinics (Juniper, Pilot, Kin, Software, Compound) on a shared proprietary platform, delivering subscription-based chronic care across Australia, the UK, Germany, Japan and Canada.
- Ownership category
- akta.pro rank
Eucalyptus industry classification
Industry- Product category
- Telehealth Healthcare Services
- NAICS
- Home Health Care Services (62161), Offices of Physicians (6211), Offices of Other Health Practitioners (6213)
- SIC
- Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care) (HLALAFAK)
- akta.pro secondary industry
- Women’s & Family Health Provider Marketplaces (HLALALAK)
Keywords
Where Eucalyptus is headquartered
LocationHeadquarters
- HQ city
- Sydney
- HQ country
- Australia
- HQ region
- Oceania
Offices6 records
Markets served
Eucalyptus business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Marketing or Sales, Technology or R&D, Supply Chain, Operations, Infrastructure
Revenue model
- Subscription Telehealth Programs: Recurring subscription-based care programs delivered through Eucalyptus' four digital clinics (Kin reproductive care, Pilot men's health, Juniper weight management, Software skincare). Patients pay ongoing fees for consults, ongoing support, prescriptions, and shipped treatments. Juniper programs combine medication with multidisciplinary health coaching via app-based delivery.
- Skincare Product Sales (Software): Sale of clinical-grade custom skincare formulations (over 70,000 custom formulations to date) and over-the-counter skincare offerings through retail partners including Priceline Pharmacy in Australia. Combines bespoke subscription delivery with retail product revenue.
- Contraceptive Pill Delivery (Kin): Recurring delivery service for contraceptive pills with over 50,000 subscribers. Includes ongoing prescriptions and delivery of medication as part of a subscription model.
- Telehealth Consultation & Treatment Fees: Per-consult and treatment-related fees across clinics, including consultations with GPs, nurse practitioners, pharmacists, and dietitians. Treatment plans integrate medication dispensing and pharmacist fulfilment where applicable.
Go-to-market motion1 record
Distribution channels4 records
Eucalyptus product offering
Product offeringCore offering
Eucalyptus operates a portfolio of subscription-based direct-to-consumer telehealth clinics (Juniper for women's weight management, Pilot for men's health, Kin for reproductive healthcare, Software for clinical-grade skincare, and Compound) delivered through its proprietary digital health platform. Patients access asynchronous and synchronous consultations with certified practitioners, receive clinician-prescribed medication, ongoing multidisciplinary coaching, and in some cases bespoke compounded or OTC treatments, paying recurring subscription fees for ongoing care and prescriptions.
Product overview
Eucalyptus operates a platform-plus-modules architecture: a single shared underlying telehealth platform (the "Eucalyptus Platform") powers a portfolio of distinct, demographic-focused digital healthcare clinic sub-brands — Pilot (men's health), Juniper (women's weight management — flagship), Kin (reproductive healthcare), Software (clinical-grade tele-skincare) and Compound — supported by shared capabilities such as the Health Records, Chat, Trends Engine, Consultation, Pathology, Flexible Plans, Purchasing and Tracking modules. The company is best known for its Juniper weight-management service, which combines clinician-prescribed pharmacotherapy (semaglutide, tirzepatide, Wegovy, Ozempic, Mounjaro) with multidisciplinary health coaching, an award-winning patient mobile app and a health-coaching trends engine; Juniper operates in Australia, the UK, Germany and Japan. Pilot, Kin and Software round out the portfolio for men's health, fertility/reproductive care and skincare respectively, and since mid-2026 Eucalyptus has operated as a subsidiary of Hims & Hers Health following a US$1.15B acquisition.
Differentiator
Problem solved
Functional benefit
Brands
- Juniper: Women's weight management telehealth clinic operating in Australia, the UK, Germany, and Japan; supported 200,000 Australian women with personalised weight treatment.
- Pilot
- Kin
- Software
- Compound
Products and services
- Juniper (women's weight management clinic) Subscription-based telehealth weight management clinic for women combining clinician-prescribed medication with ongoing multidisciplinary health coaching via app and asynchronous/synchronous consults; supports 200,000+ Australian women and operates in Australia, UK, Germany and Japan.
- Pilot (men's health clinic) Subscription telehealth clinic for men's health covering hair loss, erectile dysfunction, premature ejaculation, herpes and weight gain, with free mental-health counselling via TIACS; serving 100,000+ men in Australia.
- Kin (reproductive healthcare clinic) Subscription telehealth clinic for women's reproductive healthcare offering fertility care, recurring contraceptive pill delivery (50,000+ subscribers), and postpartum support, plus advocacy campaigns such as #weneedmoreleave and #BreastFeedingFriendly.
- Software (clinical-grade tele-skincare) Subscription telehealth skincare clinic offering bespoke, clinical-grade custom skincare formulations for acne, redness, pigmentation and skin ageing (70,000+ custom formulations) plus over-the-counter skincare products distributed at Priceline Pharmacy from 2023.
- Compound (digital health clinic) Eucalyptus digital clinic operating under compound.co, compound.health and compound.healthcare domains, referenced in the company's vulnerability disclosure programme and careers page with Lead Clinician Dr Ben Condon.
Quantifiable outcome
- Over 1 million practitioner consultations facilitated since 2019
- +9 more outcomes
Companies that use Eucalyptus
Customer profileNamed customers1 record
Ideal customer profiles3 records
Eucalyptus technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration7 records
AI capability9 records
Feature6 records
Eucalyptus partnerships and signals
Strategic signalPartnerships
Eleven partnerships are on record, tiered core, flagship and moderate.
- Hims & Hers Subscriber Benefits Brand PartnerscoreHims & Hers added eight new partner brands to its subscriber benefits program post-acquisition, including Natural Cycles, MyFitnessPal, Ladder, Pvolve, HelloFresh, Factor, Flo Health, Dexcom (Stelo), and iFIT, offering discounts and free trials across fitness, nutrition, women's health, and metabolic monitoring.
- Novo NordiskflagshipNovo Nordisk and Hims & Hers settled a prior patent lawsuit and announced a collaboration to distribute Wegovy and Ozempic through the combined Hims & Hers-Eucalyptus telehealth platform, phasing out mass marketing of compounded versions. This gives Novo Nordisk access to Hims & Hers' telehealth customer base (over 418,000 GLP-1 users) and reshapes Eucalyptus' weight-loss distribution into branded pharmaceutical channels.
- Hims & Hers Health, Inc.flagshipHims & Hers Health entered into a definitive agreement to acquire Eucalyptus for up to US$1.15 billion (AU$1.6 billion) with approximately US$240 million cash at closing plus deferred and earnout payments through early 2029. The deal closed in mid-2026. Eucalyptus founder Tim Doyle became SVP of International at Hims & Hers, expanding its consumer health platform across Australia, the UK, Canada, Germany, France, Ireland, Spain, and Japan.
- Amigo (AI Health Platform)flagshipAmigo has partnered with Eucalyptus to integrate AI agents into its portfolio of specialised virtual clinics, launching initially at Juniper (women's weight management) before expanding to other brands. The collaboration automates routine clinical tasks and provides round-the-clock patient support.
- Priceline PharmacycoreIn 2023, Software's high-performance OTC skincare offerings hit the shelves across retail partners in Australia, including Priceline Pharmacy, extending the brand's distribution beyond the Software telehealth channel.
- TIACS (This Is A Conversation Starter)moderateSince 2019, Eucalyptus' Pilot brand has partnered with TIACS to offer men free, confidential mental health counselling via call or text. Pilot provides funding and the partnership supports brand reputation in men's health while extending patient access to crisis support services.
- Australian Council on Healthcare Standards (ACHS)flagshipEucalyptus is the only telehealth company accredited by ACHS against the EQuIP6 standard, providing independent validation of clinical governance, patient safety and quality systems. ACHS accreditation is a strong differentiator versus other Australian telehealth operators.
- Randox Laboratories LtdcoreUK diagnostic and pathology partner used by Eucalyptus to facilitate blood-testing services in the UK. Both parties act as separate and independent data controllers for the testing data.
- Thriva LimitedcoreUK diagnostic and pathology partner used by Eucalyptus for at-home blood-testing kits and lab analysis. Both parties act as separate and independent data controllers for the testing data.
- Australian Government's IHI Database (Healthcare Identifiers)coreEucalyptus has integrated with Australia's Individual Healthcare Identifier (IHI) database, allowing practitioners to validate patient identity and clinical history as part of safe prescribing workflows.
- eRx Exchange (Australia)coreEucalyptus has integrated with Australia's eRx electronic prescription exchange to enable paperless prescribing and dispensing workflows across its clinics.
Scale indicators26 records
Recent moves13 records
Expansion highlights6 records
Eucalyptus competitors and assessment
Company assessmentDirect peers
- Ro: US-based direct-to-consumer telehealth operator running Roman (men's health), Rory (women's health) and Ro Body (weight management). Closely comparable to Eucalyptus in multi-brand D2C prescribing model, subscription revenue structure and category mix across men's, women's and chronic care.
- Maven Clinic: Virtual clinic for women's and family health covering fertility, maternity, postpartum and ongoing care. Directly comparable to Eucalyptus' Kin Fertility brand and adjacent to Juniper's women's weight-management focus.
- Numan: UK-based D2C telehealth clinic treating men's health conditions (hair loss, erectile dysfunction, weight loss) via subscription. Direct peer to Eucalyptus' Pilot brand and representative of the same UK men's-health D2C category where Eucalyptus competes.
- Zava: European online clinic operating across the UK, Germany, France and Ireland offering consultations, prescriptions and ongoing care for chronic and lifestyle conditions. Comparable to Eucalyptus in cross-European D2C prescription telehealth model and multi-country compliance footprint.
- Noom: US-headquartered digital health platform combining behaviour change coaching with clinician-prescribed weight-loss pharmacotherapy (GLP-1 support). Closest pure-play peer to Eucalyptus' Juniper in combining coaching, app and prescription weight-management at scale.
Broad incumbents
- Hims & Hers Health: NYSE-listed direct-to-consumer telehealth platform (HIMS) selling prescription and OTC treatments across hair, skin, sexual health, mental health and weight loss. Now Eucalyptus' parent company following the US$1.15B June 2026 acquisition, making it the closest functional peer and the channel through which Eucalyptus' brands now reach US consumers.
- Teladoc Health: NYSE-listed global virtual care incumbent offering telehealth across primary care, mental health, chronic condition management and weight management (via Livongo acquisition). Broad incumbent peer providing enterprise and consumer virtual care at much larger scale than Eucalyptus.
- Babylon Health: UK-founded digital health company offering AI-assisted triage, telehealth consultations and chronic-condition management globally. A broad incumbent peer in the UK/Europe telehealth market where Eucalyptus' Juniper and other brands operate.
Regional players
- DoktorABC: Germany-focused online telehealth and pharmacy platform offering prescription treatments across weight management, men's health and dermatology. Regional peer in Germany where Eucalyptus operates Juniper Germany, with overlapping category mix.
Emerging players
- Zoe: Personalised nutrition and metabolic health platform using at-home tests and consumer subscription coaching, with growing weight-management and cardiometabolic positioning. Emerging peer to Eucalyptus in consumer chronic-condition management with a science-led, evidence-base approach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Eucalyptus social profiles
Digital presenceEucalyptus compliance and trust
Trust signalCompliance7 records
Eucalyptus financial estimates
Financial estimateRevenue estimate
Valuation estimate
Eucalyptus leadership team
Management profileNumber of profiles
Profiles16 records
Eucalyptus subsidiaries and ownership
Company hierarchySubsidiaries5 records
Eucalyptus funding detail
Funding detailFunding overview
Funding rounds7 records
Investors8 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Eucalyptus M&A and investment
M&A and investmentM&A
Investments1 record
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Eucalyptus
What does Eucalyptus do?
Eucalyptus operates a portfolio of subscription-based direct-to-consumer telehealth clinics (Juniper for women's weight management, Pilot for men's health, Kin for reproductive healthcare, Software for clinical-grade skincare, and Compound) delivered through its proprietary digital health platform. Patients access asynchronous and synchronous consultations with certified practitioners, receive clinician-prescribed medication, ongoing multidisciplinary coaching, and in some cases bespoke compounded or OTC treatments, paying recurring subscription fees for ongoing care and prescriptions.
Is Eucalyptus a public or private company?
Eucalyptus is a private company. It is classified as corporate owned and is currently acquired.
When was Eucalyptus founded?
Eucalyptus was founded in 2019. It employs 251 to 500 people.
Where is Eucalyptus based?
Eucalyptus is headquartered in Sydney, Australia, in the Oceania region.
How does Eucalyptus make money?
Four revenue lines are on record. Subscription Telehealth Programs are the primary driver. The others are skincare Product Sales (Software), contraceptive Pill Delivery (Kin) and telehealth Consultation & Treatment Fees.
Who are Eucalyptus's main competitors?
Direct peers on record are Ro, Maven Clinic, Numan, Zava and Noom. Broad incumbents are Hims & Hers Health, Teladoc Health and Babylon Health. DoktorABC is listed as a regional player. Zoe is listed as an emerging player.
Does Eucalyptus have an API?
No public API is recorded for Eucalyptus.
What industry is Eucalyptus in?
Eucalyptus's product category is Telehealth Healthcare Services. Its primary akta.pro industry code is HLALAFAK, Behavioral Health-Integrated Chronic Care (SUD comorbidity, collaborative care), with a secondary code of HLALALAK, Women’s & Family Health Provider Marketplaces. Its NAICS code is 62161 and its SIC code is 8082.